3,4-dihydro-2-methyl-2-(4-methyl-3-pentenyl)-7-(1,1,5-trimethylhexyl)-2H-1-benzopyran-5-ol | 406217-72-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: 3,4-dihydro-2-methyl-2-(4-methyl-3-pentenyl)-7-(1,1,5-trimethylhexyl)-2H-1-benzopyran-5-ol
• 英文别名: 7-(2,6-Dimethylheptan-2-yl)-2-methyl-2-(4-methylpent-3-enyl)-3,4-dihydrochromen-5-ol
• CAS: 406217-72-9
• 化学式: C₂₅H₄₀O₂
• 分子量: 372.591
• InChiKey: XNZAGWONTRWXHV-UHFFFAOYSA-N

物化性质

• 沸点：
  466.8±44.0 °C(Predicted)
• 密度：
  0.953±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  8.6
• 重原子数：
  27
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.68
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  1-(1,1,5-trimethylhexyl)-3,4,5-trimethoxybenzene 、 香叶醇 在 对甲苯磺酸 作用下， 以 苯 为溶剂， 反应 2.0h， 以20%的产率得到3,4-dihydro-2-methyl-2-(4-methyl-3-pentenyl)-7-(1,1,5-trimethylhexyl)-2H-1-benzopyran-5-ol
  参考文献：
  名称：

  Topical formulations of resorcinols and cannibinoids and methods of use

  摘要：

  本发明提供了一种预防HIV从一个个体传播到另一个个体的方法。根据该方法，将至少包括一种间苯二酚衍生物化合物和/或大麻素（例如，大麻酚衍生物，Δ8-THC衍生物，大麻烯衍生物，大麻二酚衍生物，大麻醇衍生物）（包括其组合）的药理学可接受的组合物局部给第一具有HIV的个体，或在第一具有HIV的个体和第二个个体之间的接触时间接近时局部给第二个有HIV感染风险的个体。本发明还提供了至少包括一种间苯二酚和/或大麻素以及水不溶性聚合物作为水凝胶的局部制剂。

  公开号：

  US20030232101A1

文献信息

• Antiviral methods and compounds
  申请人：——

  公开号：US20020068738A1

  公开（公告）日：2002-06-06

  The invention provides a method, compounds, and compositions for inhibiting the replication or proliferation of a virus. In accordance with the invention, at least one cannabichromene derivative is exposed to the virus, a host cell, or an infected cell under conditions sufficient to inhibit the replication or proliferation of the virus.

  本发明提供了一种抑制病毒复制或增殖的方法、化合物和组合物。根据本发明，在足以抑制病毒复制或增殖的条件下，将至少一种大麻色烯衍生物暴露于病毒、宿主细胞或受感染细胞。
• US6541510B2
  申请人：——

  公开号：US6541510B2

  公开（公告）日：2003-04-01
• [EN] ANTIVIRAL METHODS AND COMPOUNDS<br/>[FR] PROCEDES ANTIVIRAUX ET COMPOSES
  申请人：IMMUGEN PHARMACEUTICALS INC

  公开号：WO2002026728A2

  公开（公告）日：2002-04-04

  The invention provides a method, compounds, and compositions for inhibiting the replication or proliferation of a virus. In accordance with the invention, at least one cannabichromene derivative is exposed to the virus, a host cell, or an infected cell under conditions sufficient to inhibit the replication or proliferation of the virus.
• [EN] TOPICAL FORMULATIONS OF RESORCINOLS AND CANNIBINOIDS AND METHODS OF USE<br/>[FR] PREPARATIONS TOPIQUES DE RESORCINOLS ET DE CANNABINOIDES ET LEURS PROCEDES D'UTILISATION
  申请人：IMMUGEN PHARMACEUTICALS INC

  公开号：WO2003080043A1

  公开（公告）日：2003-10-02

  In one aspect, the invention provides a method for preventing the transmission of HIV from one individual to another. In accordance with the method, a pharmacologically­acceptable composition including at least one resorcinol derivative compound and/or cannabinoid (e.g., cannabdol derivatives, Δ8-THC derivatives, cannabichromene derivatives, cannabidiol derivatives, cannabigerol derivatives) (including combinations thereof) is administered topically to a first individual harboring HIV, or to a second individual at risk of infection with HIV, proximate in time with contact between the first individual and the second individual. The invention also provides topical formulations of at least one resorcinol and/or cannabinoid and water insoluble polymers as hydrogels.
• Topical formulations of resorcinols and cannibinoids and methods of use
  申请人：Immugen Pharmaceuticals, Inc.

  公开号：US20030232101A1

  公开（公告）日：2003-12-18

  In one aspect, the invention provides a method for preventing the transmission of HIV from one individual to another. In accordance with the method, a pharmacologically-acceptable composition including at least one resorcinol derivative compound and/or cannabinoid (e.g., cannabinol derivatives, &Dgr;8-THC derivatives, cannabichromene derivatives, cannabidiol derivatives, cannabigerol derivatives) (including combinations thereof) is administered topically to a first individual harboring HIV, or to a second individual at risk of infection with HIV, proximate in time with contact between the first individual and the second individual. The invention also provides topical formulations of at least one resorcinol and/or cannabinoid and water insoluble polymers as hydrogels.

  本发明提供了一种预防HIV从一个个体传播到另一个个体的方法。根据该方法，将至少包括一种间苯二酚衍生物化合物和/或大麻素（例如，大麻酚衍生物，Δ8-THC衍生物，大麻烯衍生物，大麻二酚衍生物，大麻醇衍生物）（包括其组合）的药理学可接受的组合物局部给第一具有HIV的个体，或在第一具有HIV的个体和第二个个体之间的接触时间接近时局部给第二个有HIV感染风险的个体。本发明还提供了至少包括一种间苯二酚和/或大麻素以及水不溶性聚合物作为水凝胶的局部制剂。